Search

everythinglearnresearchcommunity

for

Search:↓

Mutations at Val-889 and Arg-752 disrupt key interactions in the androgen receptor, affecting its function.

Androgens can both increase and decrease hair growth in different parts of the body.

Insulin changes sex hormone levels in women with polycystic ovary syndrome without affecting other hormone releases.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Androgen levels increase with puberty and are linked to sexual hair development.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Prepubertal girls have higher sex steroid levels than boys, possibly leading to earlier puberty.

Male and female mice have different skin thickness, and hormones affect their skin and hair growth differently.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Finasteride safely lowers DHT levels without affecting testosterone.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

2-Methoxyestradiol causes cancer cell death by activating specific pathways, but androgens can block this effect.

Testosterone's muscle-building effects do not require its conversion to DHT.

5 alpha-reductase inhibitors, like finasteride, are used to treat conditions like prostate issues and skin disorders.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.